Encoded Therapeutics is a developer of precise gene therapies, designed to offer treatments for a wide array of serious genetic conditions. The company's therapeutic pipeline tackles severe genetic and acquired disorders that span numerous disease pathways such as neurocircuitry, metabolic disorders, neurodegeneration, and heart disease. This allows healthcare professionals to treat patients and enhance their quality of life.

Investors Include:

RONA Holdings, GV, Alta Partners, SoftBank Investment Advisers, QB3, HBM Genomics, Illumina Ventures, Boxer Capital, RTW Investments, Matrix Capital Management, Nolan Capital, Altitude Life Science Ventures, Menlo Ventures, Farallon Capital Management, Alexandria Venture Investments, Springboard Enterprises, Meritech Capital Partners, Biobrit, Green Sands Equity, ARCH Venture Partners.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund